AMYLINDERIVATE

Patent europeic · EP2718316 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2718316
Numer da la dumonda
EP12729418
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
08-06-2012
Publitgà
16-04-2014
Concedì
04-12-2019
La protecziun finescha il pli tard
07-06-2032
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 14/575 (2006.01)
A61K 38/22 (2006.01)
A61K 47/54 (2017.01)
A61K 38/00 (2006.01)
Prioritad
EP 11169405 10.06.2011
US 201161496113 P 13.06.2011
Dumonda PCT
PCT/EP2012/060900 08.06.2012
Publicaziun PCT
WO2012/168432 13.12.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  4. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  5. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  6. 04-12-2019

    Concedì

    Published in Swissreg on 04.12.2019

Partidas

Possessur

Novo Nordisk A/S

Novo Allé, 2880 Bagsværd, DK

Inventur

KRUSE, Thomas

DK-2880 Bagsværd, DK

THØGERSEN, Henning

DK-2880 Bagsværd, DK

SCHÄFFER, Lauge

DK-2880 Bagsværd, DK

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.